KATE FERRARELLO: Open Payments
NPI 1730170002 · SINKING SPRING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,792 in 123 payments from 17 companies in 2025. Trend: 2023 $2,785 · 2024 $2,470 · 2025 $2,792
Food & beverage: $2,572Education: $220
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $613 |
| Janssen Biotech, Inc. | 20 | $470 |
| Regeneron Healthcare Solutions, Inc. | 10 | $338 |
| Galderma Laboratories, L.P. | 16 | $268 |
| GENZYME CORPORATION | 8 | $254 |
| Novartis Pharmaceuticals Corporation | 10 | $200 |
| Amgen Inc. | 9 | $200 |
| LEO Pharma Inc. | 3 | $76 |
| Arcutis Biotherapeutics, Inc. | 4 | $75 |
| Organon LLC | 5 | $68 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, NEMLUVIO, OTEZLA, COSENTYX, RINVOQ, Zoryve.
Industry payments across PA — which companies pay providers there.
